Ventura Cannabis and Wellness Corp (OTCMKTS:CVHIF) posted substantial earnings in 2020. Its cash balance as of February 29, 2020, is $3.9 million.
In California, Ventura Cannabis possesses a type 6 license for manufacturing medical use and adult-use cannabis on 700 SQ. Ft. facility in San Francisco Bay. It also possesses a type 11 distribution license for medical use and adult-use cannabis statewide. The company also holds a significant stake in a Sacramento based delivery only AUDL (adult-use dispensary license).
Sacramento, CA-based premium delivery service – Kush Rush serves the population in the greater Sacramento and adjoining areas. Kush Rush is credited with a reputation for high quality, discrete delivery, and incredible customer service.
Kush Rush offers a variety of products at competitive rates by employing highly qualified operators. Even couriers are trained to provide reliable information about high-quality products of Venture Cannabis to the customers.
Recreational marijuana dispensary – Amberlight Cannabis based in the Richmond neighborhood provides excellent customer service in a friendly and clean environment. Customers can get personalized experience in selecting concentrates, edibles, and accessories.
Significant revenue potential
Ventura Cannabis expects to generate significant revenues when assets, including vape brands in California, are fully functional. The company also holds a retail dispensary for medical and adult-use cannabis in Portland, Oregon, to generate considerable revenues.
CEO of Ventura Cannabis, Chris Heath, said its team played a vital role in introducing high-quality cannabis assets in challenging market conditions in Oregon and California in a short period. It helped the company to maintain a strong balance sheet.
Focuses on underserved segments
Ventura Cannabis focuses on underserved and large segments in the US cannabidiol and cannabis markets to serve female professionals aged above 40 years, males, and senior citizens also those with addiction.
Ventura Cannabis provides CBD and cannabis products in a precise dose to the patients in the US to cure addiction. The market for medical marijuana and recreational marijuana in the US expects to reach $13.22 billion and $10.86 billion by 2025. Global demand for legal cannabis expects to reach $45 billion by the year 2027 from $12 billion in 2018.
Emerald Health Therapeutics Inc. (OTCMKTS:EMHTF) Introduces Pure Sunfarm Products In Manitoba As Its Terminates Facility Agreements
Post Views: 100 Emerald Health Therapeutics Inc. (OTCMKTS:EMHTF) has announced that its cannabis production joint venture Pure Sunfarms has started...
Planet 13 Holdings Inc. (OTCMKTS:PLNHF) Signs Purchase Agreement To Acquire 45,000 Sq. ft. Facility In Nevada
Post Views: 190 Planet 13 Holdings Inc. (OTCMKTS:PLNHF) announced the signing of an asset purchase agreement subject to which it...
AXIM® Biotechnologies Inc. (OTCMKTS:AXIM) Unveils its NeuCovix™ Test That Can Accurately Classify COVID-19 Neutralization Tests
Post Views: 61 AXIM® Biotechnologies Inc. (OTCMKTS:AXIM) has completed a study focusing on the performance of its NeuCovix™ rapid test...
Indus Holdings Inc. (OTCMKTS:INDXF) Terminates Its Pending $20 million Acquisition Agreement Of W Vapes Assets
Post Views: 185 Indus Holdings Inc. (OTCMKTS:INDXF) announced termination of its impending acquisition of W Vapes assets that was announced...
1933 Industries Inc. (OTCMKTS:TGIFF) Introduces Pre-roll Joints And Smokable Cannabis Flower In Nevada
Post Views: 165 1933 Industries Inc. (OTCMKTS:TGIFF) announced addition of pre-joint rolls and high-quality smokable flowers to its growing consumer...
Cannabis Pharmaceuticals Inc. (OTCMKTS:CNBX) Initiates Expansion Of Its Cannabinoid Diagnostic Platform Tests In Europe
Post Views: 134 Cannabis Pharmaceuticals Inc. (OTCMKTS:CNBX) commenced expansion in the European markets to offer cancer patients tailored cannabinoid treatment...